Tomorrow's Press Panel! What Biopharma Journalists Are Watching in China


Hi!

A quick reminder that our next press panel is tomorrow, brought to us by T2B's Media Minds Roundtable. Drew Armstrong (Endpoints News) and Angus Liu (Fierce Pharma) will join to talk about the stories they're following involving China’s growing role in global biopharma, and the issues they expect will shape coverage in 2027.

From cross-border licensing and drug discovery to geopolitical tensions, investment, and supply chains, we'll dig into how journalists are navigating the competing scientific, commercial, and political narratives, and what that means for communicators.

The China Biopharma Scene: Topics & Issues Journalists Are Watching in 2026-2027

📅 Friday, November 6th @ 12-1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. GMT

📍 Zoom

🎟️ Register here.​

Free and exclusive to T2B Pro and Student members.

Questions we'll explore:

  • Which China-related biotech stories are gaining momentum, and what will drive coverage in 2027?
  • How are journalists weighing the scientific and commercial opportunities against geopolitical and national security concerns?
  • What questions should companies be prepared to answer about Chinese partnerships, IP, data, and supply-chain exposure?
  • How are reporters finding and verifying credible information, and what makes a company or executive a useful source?

Special thanks to Media Minds Roundtable members Danielle Cantey and Cammy Duong (LifeSci Communications), who will co-moderate the discussion.

This session is part of our member-driven roundtable programming, which aims to help communicators better understand how journalists think about the stories shaping our industry, so we can be more thoughtful and effective in how we engage with them.

Hope to see you tomorrow!

Lynnea

P.S. - If you're not already a T2B Pro member, you can upgrade here to join this discussion and our other member-led roundtable events.

T2B Monthly

Read more from T2B Monthly

Hi! Sometimes being successful as a communicator means … nothing actually happens. An emerging issue never becomes a crisis, a major organizational change unfolds without confusion, or a potentially problematic decision is reconsidered before it creates reputational risk. Our upcoming November Comm Convo will be a discussion about recognizing and articulating a part of our profession's value that often goes unnoticed – precisely because we've done our jobs well. We’ll address the challenge...

Hi! Your employer brand says a lot about your broader corporate reputation. But how closely does the story your company tells match what employees experience, what candidates discover, and what others say about working there? At our most recent Culture Connect Roundtable session, we explored what makes an employer brand credible, particularly during periods of growth, restructuring, and significant change. Carolin Groh (BioNTech), Tom Karim (Cytiva), Charlotte Marshall (Give & Get Employer...

Hi! “The press release is dead” is a popular refrain these days. But as AI changes how people search for and discover information, press releases are more than just a formality, and may offer a different kind of value: They now serve as source material for search engines, AI platforms, investors, patients, and anyone trying to understand a company's science, pipeline, or latest developments. At our most recent Digital & Social Media Roundtable session, our speakers explored what this means...